Asterion Cannabis Inc. President and COO Hamish Sutherland recently joined Proactive Investors to talk about the company’s Australian cannabis project and the opportunities the Australian cannabis market presents. The interview started with Sutherland’s views on the opportunities in the Australian cannabis industry. According to Sutherland, investors are looking to cannabis markets outside of North America for regions that are set up to serve the global markets quickly.
“Typically people look at the US as the elephant in the room, but the rest of the world is equally sized and equally moving forward with cannabis legislation,” said Sutherland. “Australia is well-poised to fulfill that role as the current Minister of Health has declared he’s seeking and looking forward to Australia establishing a role as one of the global suppliers. One of the reasons for that is that it is a regulated environment and market with a clear and consistent government on which other countries can rely.”
Sutherland went on to talk about Canopy Growth Corporation’s (NYSE:CGC,TSX:WEED) sale of its 13.2 percent interest in AusCann Group Holdings and what this means for the space moving forward. Sutherland feels that this will let other experienced, established cannabis companies to expand their offerings and move into the global cannabis markets. According to Sutherland, Asterion has the largest, purpose-built greenhouse in Australia that is designed to serve not only the Australia market but the global markets as well.
Asterion has submitted its licensing applications to the Australian Office of Drug Control (ODC) and expects to receive its licenses within the coming months. Sutherland emphasized that the company was working closely with the ODC to ensure that the company is compliant with all current and future regulations. The company is also working with several interested parties to ensure that Asterion can mitigate any pitfalls that have so far been experienced in North America.
To watch the full interview, click here.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Numinus Bioscience adds Ketamine and LSD to licence to produce, assemble and sell a wide variety of psychedelic compounds
Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI ), a global leader in supporting and expanding the safe, accessible and evidence-based use of psychedelic-assisted psychotherapies (PAP), has received new amendments under Canada’s Controlled Drugs and Substances Act that enhance the Company’s ability to lead psychedelics research and support the global psychedelics sector.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact firstname.lastname@example.org, or